ULURU INC. to Present at the Diabetic Foot Global Conference

03/13/2009

Addison, Texas, March 13, 2009; ULURU Inc. (NYSE Alternext: ULU) announced that clinical evidence on the treatment of diabetic foot ulcers, and data on the use of its patented Nanoflex™ Technology for Therapeutic Delivery will be presented at the annual DFCon Global Meeting in Los Angeles, California March 19-21. The work will be presented on posters that will be on display during the meeting. Read More